Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antiemetic drugs, such as ondansetron, may help to reduce or prevent nausea and
vomiting in patients with advanced cancer.
PURPOSE: This randomized phase III trial is studying how well ondansetron works compared to a
placebo in treating patients with advanced cancer and chronic nausea and vomiting that is not
caused by cancer therapy.